ARCHIVES

FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Trials Approved by NCI CTEP Last Month

November 25, 2011

Correcting the Error: What U.S. News Could and Couldn’t Do to Fix the Problem

July 19, 2013

HEW Secretary Tells Ethics Board To Take Up Issue of Compensation

September 28, 1979

In Brief: FDA Advisors Ask Cetus To Refine IL-2 Application; NIH Reauthorization Introduced

August 3, 1990

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

Silicone Implants Not Linked To Increased Risk Of Death

May 25, 2001